Page 1 of Clinical Trials for PhaseBio Pharmaceuticals Inc. [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Study to Assess Safety, Tolerability, PK and PD Response of PB1023 Injection Following Single and Multiple SQ Doses in Adults With Type 2 Diabetes Mellitus
Last Updated: November 18, 2011
Condition(s): Diabetes Mellitus, Type 2
2
Recruiting
Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus
Last Updated: February 23, 2012
Condition(s): Diabetes Mellitus, Type 2
3
Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension
Last Updated: March 5, 2012
Condition(s): Essential Hypertension
4
Recruiting
Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function
Last Updated: January 4, 2012
Condition(s): Diabetes Mellitus, Type 2

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=PhaseBio+Pharmaceuticals+Inc.

Page 1 of Clinical Trials for PhaseBio Pharmaceuticals Inc. [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About